Mebendazole
Benzimidazole Derivatives
Sold as VERMOX · OVEX SUSPENSION
- Drug class
- Benzimidazole Derivatives
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 7
Overview
Mebendazole is an active pharmaceutical ingredient in the Benzimidazole Derivatives group (P02CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 6 | May 29, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
GBUnited Kingdom· MHRA
6 products
Uses
For the treatment of gastrointestinal infestations of Enterobius vermicularis (threadworm). There is no evidence that Ovex is effective in the treatment of cysticercosis. Official guidelines should be taken into consideration.
How to take
CACanada· Health Canada
1 product
Uses
Vermox (mebendazole) is indicated for a broad spectrum of anthelmintic activity and is effective in the treatment of single or mixed helminthic infestations. Clinical studies have shown it to be effective in the treatment of Enterobius vermicularis (pinworm); Ascaris lumbricoides (roundworm); Trichuris trichiura (whipworm); Ancylostoma duodenale and Necator americanus (hookworm).
It has also been used to treat infestations due to Strongyloides stercoralis (threadworm) and Taenia solium (large tapeworms). 1 Pediatrics Pediatrics (1 to <18 years of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of Vermox in pediatric patients has been established.
3 Pediatrics).
How to take
Drug interactions
Known interactions involving Mebendazole. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL155130314 · revised March 6, 2026
- [2]Health Canada (DPD) · 00556734 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.